GL1X · GenesisL1 explorer

MolNFT v2 · #227280 · protein

9C55: Crystal structure of human PTPN2 in complex with active site inhibitor

9C55 · Tyrosine-protein phosphatase non-receptor type 2: “Crystal structure of human PTPN2 in complex with active site inhibitor”. X-ray diffraction at 2.36, 1 ligand (527), 2 pockets (best druggability 0.49). MolNFT v2 #227280 on…

3D structure of 9C55: Crystal structure of human PTPN2 in complex with active site inhibitor (MolNFT v2 / PDB Bank)
3D structure of 9C55: Crystal structure of human PTPN2 in complex with active site inhibitor (MolNFT v2 / PDB Bank)
PDB
9C55
Type
protein
Length
288 residues
Chains
1
Method
x-ray diffraction
Authors
Bester, S.M., Linwood, R., Wu, W.-I., Mou, T.-C.
Deposited
06/05/24
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.36
Source
Homo sapiens
Molecule
Tyrosine-protein phosphatase non-receptor type 2
EC
3.1.3.48
UniProt
P17706
Ligands
527
Pockets
2 · best druggability 0.49

Structure

x-ray diffraction · resolution 2.36 · 1 distinct chain · 36% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48)protein28836% helix, 20% strandP17706

Ligands and binding sites

  • 527 · 5-(3-{[1-(benzylsulfonyl)piperidin-4-yl]amino}phenyl)-4-bromo-3-(carboxymethoxy)thiophene-2-carboxylic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1720.490.8414527
2620.270.7313empty

Compared structures

  • P17706 · AlphaFold monomer V2.0 prediction for tyrosine-protein phosphatase non-receptor type 2… · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.